Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis - Catrina, A I; Lampa, J; Ernestam, S (Rheumatology (Oxford), 2002)
et al.